RAF1 and cancer: The mammalian family of MAPKs is represented by 14 members and organized into seven signaling pathways with the archetypal, RAS-dependent RAF-MEK1/2-ERK1/2 module at the forefront of the drug development research in cancer (Cargnello and Roux, 2011; Degirmenci et al., 2020).